ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour-Reference-Cited by-同舟云学术

ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour

Published:2012-02-17 Issue:2 Volume:227 Page:223-233
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Edris Badreddin,Espinosa Iñigo,Mühlenberg Thomas,Mikels Amanda,Lee Cheng-Han,Steigen Sonja E,Zhu Shirley,Montgomery Kelli D,Lazar Alexander JF,Lev Dina,Fletcher Jonathan A,Beck Andrew H,West Robert B,Nusse Roel,van de Rijn Matt

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/path.3986/fullpdf

Reference18 articles.

1. Gene expression profiling for the investigation of soft-tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers;Beck;Virchows Arch,2009

2. Acquired resistance to imatinib in gastrointestinal stromal tumours occurs through secondary gene mutation;Antonescu;Clin Cancer Res,2005

3. The discovery of receptor tyrosine kinases: targets for cancer therapy;Gschwind;Nat Rev Cancer,2004

4. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5A/JNK signalling pathway;Oishi;Genes Cells,2003

5. Ror2, encoding a receptor-like tyrosine kinase, is required for cartilage and growth plate development;DeChiara;Nat Genet,2000

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ROR2 deficit may induce the tetralogy of Fallot via down‐regulating of β‐catenin/SOX3/HSPA6 in vitro and in vivo;Journal of Cellular and Molecular Medicine;2023-09-25

2. Non-canonical WNT5A-ROR signaling: New perspectives on an ancient developmental pathway;Current Topics in Developmental Biology;2023

3. Proteomic profiling of canine fibrosarcoma and adjacent peritumoral tissue;Neoplasia;2023-01

4. Role of ROR2 in promoting gastric cancer metastasis by enhancing c-JUN-mediated MMP3 transcription;Annals of Translational Medicine;2022-10

5. Cellular and molecular mechanisms implicated in the dual role of ROR2 in cancer;Critical Reviews in Oncology/Hematology;2022-02